Conditional signaling by Toll-like receptor 4.

scientific article published on 28 February 2005

Conditional signaling by Toll-like receptor 4. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1096/FJ.04-3211FJE
P698PubMed publication ID15738005
P5875ResearchGate publication ID7995921

P50authorGeoffrey B JohnsonQ39051875
P2093author name stringJeffrey L Platt
Gregory J Brunn
Marlo K Bungum
P433issue7
P407language of work or nameEnglishQ1860
P921main subjecttoll-like receptorQ408004
P304page(s)872-874
P577publication date2005-02-28
P1433published inFASEB JournalQ520194
P1476titleConditional signaling by Toll-like receptor 4.
P478volume19

Reverse relations

cites work (P2860)
Q37741926Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention
Q34789304An extracellular subtilase switch for immune priming in Arabidopsis.
Q34720848Cleavage and activation of a Toll-like receptor by microbial proteases
Q35881486Cleavage of PGRP-LC receptor in the Drosophila IMD pathway in response to live bacterial infection in S2 cells
Q34035570DAMPening inflammation by modulating TLR signalling
Q50774937Damage-associated molecular patterns (DAMPs) released after burn are associated with inflammation and monocyte activation.
Q34803633Differential regulation of endothelial cell activation by complement and interleukin 1alpha
Q36550370Echinococcus granulosus Antigen B binds to monocytes and macrophages modulating cell response to inflammation
Q37316197Emerging role of Toll-like receptors in atherosclerosis
Q34295352Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics
Q37273605Endogenous signals initiating inflammation in the injured nervous system
Q36557953Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?
Q37013881Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease
Q37448034Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner
Q33938566Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses.
Q38263533Fungal glycans and the innate immune recognition
Q37971025Fungal surface and innate immune recognition of filamentous fungi
Q33747297Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors
Q58585910Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity
Q47888806Heparan Sulfate Proteoglycans as Relays of Neuroinflammation.
Q37983752Heparanase enzyme in chronic inflammatory bowel disease and colon cancer
Q38080632Heparanase in inflammation and inflammation-associated cancer
Q33761544Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice
Q34876266Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice
Q38985052Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy
Q90183482Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling
Q60931211Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events
Q42587945Heparanase: From basic research to therapeutic applications in cancer and inflammation
Q27025052Involvement of heparanase in atherosclerosis and other vessel wall pathologies
Q43285983Isolated closed minor-muscle injury of the lower leg did not cause an obvious systemic immune response
Q36542354Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression
Q35102577Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme
Q37444400Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock
Q37398627Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart.
Q34110914Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells
Q28396123Microglial Heparan Sulfate Proteoglycans Facilitate the Cluster-of-Differentiation 14 (CD14)/Toll-like Receptor 4 (TLR4)-Dependent Inflammatory Response
Q33714011Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP.
Q59375743Monocyte-mediated T cell suppression by HIV-2 envelope proteins
Q38704770Novel regulators of cardiac inflammation: Matricellular proteins expand their repertoire
Q47377873Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression
Q35646306Peptide 19-2.5 inhibits heparan sulfate-triggered inflammation in murine cardiomyocytes stimulated with human sepsis serum
Q36841275Profiling of the dynamically alteredgene expression in peripheral nerve injury using NGS RNA sequencing technique
Q37546836Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts.
Q51084635Relevance of meniscal cell regional phenotype to tissue engineering.
Q38222891Repair of the Peripheral Nerve-Remyelination that Works.
Q35091107Role of IL-1 receptor-associated kinase-M (IRAK-M) in priming of immune and inflammatory responses by nitrogen bisphosphonates
Q41092935Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion.
Q36885661Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14.
Q36101233Significance of heparanase in cancer and inflammation
Q39690963Surviving lethal septic shock without fluid resuscitation in a rodent model
Q37023850TLR2 in murine atherosclerosis
Q42004230The Role of Heparanase in the Pathogenesis of Acute Pancreatitis: A Potential Therapeutic Target
Q35067827The ectodomain of the Toll-like receptor 4 prevents constitutive receptor activation
Q36452903The potential of heparanase as a therapeutic target in cancer
Q93206516The role of innate immunity in mucopolysaccharide diseases
Q57090611Toll-Like Receptor Signaling Is Critical for Wallerian Degeneration and Functional Recovery after Peripheral Nerve Injury
Q42183900Toll-Like Receptors and Myocardial Ischemia/Reperfusion, Inflammation, and Injury
Q34321742Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis
Q38196396Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression
Q64961502Understanding the Role of Innate Immunity in the Response to Intracortical Microelectrodes.
Q33770777Versatile role of heparanase in inflammation
Q35232779Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury

Search more.